CORIELL INSTITUTE FOR MEDICAL RESEARCH

CAMDEN, NJ

Oncologysmall moleculeGrant-only

Compare Sign in to watch

What changed

NIH R01 · $0.7M · Targeting alternative isoform variation for TCR discovery in platinum-resistant ovarian cancer

2mo agoGrant renewalMay 19, 2026Source filing (opens the source filing in a new tab)

Momentum

82no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

8,719 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R25 · $162k · non-dilutive
May 4, 2026
CHILDREN'S HOSP OF PHILADELPHIA · PI LOWENTHAL, ELIZABETH DAWN · NICHD · award ends Apr 30, 2031 · Advancing Child Health: Preparing the Next Generation of Pediatric Researchers
NIH RePORTER · NIH RePORTER 11334524 (opens the source filing in a new tab)
Grant
R01 · $756k · non-dilutive
Mar 15, 2026
UNIVERSITY OF PENNSYLVANIA · PI KLEIN, PETER S · NIDDK · award ends Jan 31, 2030 · Targeting mitophagy through PINK1 splicing in MDS
NIH RePORTER · NIH RePORTER 11297039 (opens the source filing in a new tab)
Grant
R01 · $3.2M · non-dilutive
Sep 15, 2025
UNIVERSITY OF PENNSYLVANIA · PI KLEIN, PETER S · NIDDK · award ends Aug 31, 2029 · Mitochondrial dysfunction driven by splicing factor mutations in MDS
NIH RePORTER · NIH RePORTER 11234654 (opens the source filing in a new tab)
Grant
R01 · $756k · non-dilutive
Mar 12, 2025
CHILDREN'S HOSP OF PHILADELPHIA · PI LIAO, ERIC CHIEN-WEI · NICHD · award ends Feb 28, 2030 · Comprehensive identification and functional study of Esrp-regulated isoforms during epithelial-mesenchymal transition.
NIH RePORTER · NIH RePORTER 11301930 (opens the source filing in a new tab)
Trial
NA registered
Jan 1, 2025
Breast Cancer · RECRUITING · sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University · Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression
ClinicalTrials.gov · NCT06741540 (opens the source filing in a new tab)
Grant
R21 · $128k · non-dilutive
Sep 15, 2024
CORIELL INSTITUTE FOR MEDICAL RESEARCH · PI HUANG, JIAN · NHLBI · award ends Jul 31, 2026 · Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists
NIH RePORTER · NIH RePORTER 11187213 (opens the source filing in a new tab)
Grant
R21 · $122k · non-dilutive
Sep 1, 2024
UNIVERSITY OF PENNSYLVANIA · PI PARALKAR, VIKRAM R. · NHLBI · award ends Aug 31, 2026 · A map of ribosomal RNA regulation in human hematopoiesis
NIH RePORTER · NIH RePORTER 11169056 (opens the source filing in a new tab)
Grant
R01 · $682k · non-dilutive
Jun 18, 2024
UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MEMARZADEH, SANAZ · NCI · award ends May 31, 2029 · Targeting alternative isoform variation for TCR discovery in platinum-resistant ovarian cancer
NIH RePORTER · NIH RePORTER 11332288 (opens the source filing in a new tab)
Grant
T32 · $2.9M · non-dilutive
Jul 1, 2023
UNIVERSITY OF PENNSYLVANIA · PI BRASS, LAWRENCE F · NIGMS · award ends Jun 30, 2028 · Medical Scientist Training Program
NIH RePORTER · NIH RePORTER 11362029 (opens the source filing in a new tab)
Grant
R01 · $316k · non-dilutive
Sep 17, 2022
UNIVERSITY OF SOUTH FLORIDA · PI VARMA, SAMEER · NIGMS · award ends Aug 31, 2026 · Molecular mechanisms of lithium action on kinases
NIH RePORTER · NIH RePORTER 11180996 (opens the source filing in a new tab)
Grant
R01 · $828k · non-dilutive
Sep 15, 2022
CHILDREN'S HOSP OF PHILADELPHIA · PI WALLACE, DOUGLAS C · NIA · award ends May 31, 2027 · Role of Adaptive Immunity in Etiology of Alzheimer’s Disease andAlzheimer’s Disease-Related Dementias
NIH RePORTER · NIH RePORTER 11325815 (opens the source filing in a new tab)
Grant
R01 · $635k · non-dilutive
May 1, 2022
CHILDREN'S HOSP OF PHILADELPHIA · PI WALLACE, DOUGLAS C · NCI · award ends Apr 30, 2027 · Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA
NIH RePORTER · NIH RePORTER 11320816 (opens the source filing in a new tab)
Grant
T32 · $354k · non-dilutive
Jul 1, 1979
UNIVERSITY OF PENNSYLVANIA · PI BRASS, LAWRENCE F · NHLBI · award ends Jun 30, 2029 · Hematology Clinical Research Training Program
NIH RePORTER · NIH RePORTER 11110429 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 58%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R01 · $0.7M · Targeting alternative isoform variation for TCR discovery in platinum-resistant ovarian cancer
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Role of Adaptive Immunity in Etiology of Alzheimer’s Disease andAlzheimer’s Disease-Related Dementias
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R25 · $0.2M · Advancing Child Health: Preparing the Next Generation of Pediatric Researchers
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH T32 · $2.9M · Medical Scientist Training Program
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Targeting mitophagy through PINK1 splicing in MDS
4mo agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Comprehensive identification and functional study of Esrp-regulated isoforms during epithelial-mesenchymal transition.
4mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $3.2M · Mitochondrial dysfunction driven by splicing factor mutations in MDS
10mo agoNew grantSource (opens the source filing in a new tab)
NIH R21 · $0.1M · A map of ribosomal RNA regulation in human hematopoiesis
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH T32 · $0.4M · Hematology Clinical Research Training Program
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R21 · $0.1M · Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.3M · Molecular mechanisms of lithium action on kinases
11mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression
Feb 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression
Feb 2025Trial recruitingSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

R25 · $162k · non-dilutive

R01 · $756k · non-dilutive

R01 · $3.2M · non-dilutive

R01 · $756k · non-dilutive

NA registered

R21 · $128k · non-dilutive

R21 · $122k · non-dilutive

R01 · $682k · non-dilutive

T32 · $2.9M · non-dilutive

R01 · $316k · non-dilutive

R01 · $828k · non-dilutive

R01 · $635k · non-dilutive

T32 · $354k · non-dilutive